Licensed healthcare providers design treatment plans tailored to your unique health profile, ensuring your journey is as effective and safe as possible
With the launch of our pre-filled syringes, we are widening the choice available to doctors and patients, alongside the pen options we have already introduced," said Vikas Gupta, Chief Executive Officer of Alkem
People with uncontrolled high blood pressure Anyone with significant cardiovascular disease Pregnant or nursing women People taking certain blood pressure medications Children and adolescents under 18 Anyone with a known peptide allergy Our Medical Director reviews your full health history during your consultation to make sure peptide therapy is safe for you
What Options Are Available Right Now
For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)